FindTrial
Sign In

Association of Probiotics With Neurostimulation of Dermatome T6: Effect on Weight Loss in Obese Patients

Association of Probiotics Intake With Percutaneous Electrical Neurostimulation of Dermatome T6 (PENS T6): Effect on Weight Loss in Obese Patients

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03872245
Enrollment
20
Registered
2019-03-13
Start date
2019-03-11
Completion date
2019-05-31
Last updated
2019-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Loss

Brief summary

Patients will be randomized into 2 groups: * Group 1:Patients undergoing PENS T6, who also received Probiotics, during 10 weeks. * Group 2: Patients undergoing PENS T6 during 10 weeks. They will not received Probiotics Weight loss after 10 weeks of treatmente will be assessed.

Detailed description

Patients will be randomized into 2 groups: * Group 1:Patients undergoing percutaneous electrical stimulation of dermatome T6 (PENS T6), who also received Probiotics (Adomelle 1 caps/12h), during 10 weeks. * Group 2: Patients undergoing PENS T6 during 10 weeks. They will not received Probiotics Weight loss after 10 weeks of treatmente will be assessed.

Interventions

BIOLOGICALProbiotics

The patients will receive Adomelle 1caps/12h during 10 weeks

PROCEDUREPENS T6

The patients will undergo percutaneous electrical neurostimulation of dermatome T6 weekle, during 10 weeks

Sponsors

Hospital General Universitario Elche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* BMI \> 30 Kg/m2

Exclusion criteria

* Patients with pacemakers or implanted electrical devices. * Pregnant women * History of allergy to Probiotics

Design outcomes

Primary

MeasureTime frameDescription
Weight loss10 weeksWeight loss after treatment will be assessed

Contacts

Primary ContactJaime Ruiz-Tovar
jruiztovar@gmail.com630534808
Backup ContactOscar Lorenzo
Olorenzo@fjd.es

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026